- Children exposed to Swedish snus (a moist, powdered tobacco placed between the gums and upper lip) in the womb have higher systolic blood pressure than children not exposed to nicotine products during fetal development.
Embargoed until 4 a.m. CT / 5 a.m. ET Wednesday, Oct. 16, 2019
DALLAS, Oct. 16, 2019 — Five to six year old children had higher systolic blood pressure if their mothers used snus, a moist, powdered smokeless tobacco that contains nicotine, while pregnant compared to children of mothers who did not use snus, according to new research published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
The European Union banned the sale of snus in 1992, after a 1985 World Health Organization (WHO) study concluded it was carcinogenic to humans. Snus remains popular in Sweden,is now available in the U.S. and is currently under review by the U.S. Food and Drug Administration. Placed between the gums and upper lip, snus delivers high doses of nicotine yet does not include the combustible by-products found in smoked tobacco. Unlike typical American chewing tobacco or “dip,” there is no need to spit when using snus.
“Nicotine use during pregnancy, regardless of whether it is in snus, cigarettes, smoked tobacco or vaped tobacco products, is not safe and may have a negative impact on the future health of the child. Nicotine easily passes through the placenta and reaches the developing fetus,” said lead author Felicia Nordenstam, M.D., Ph.D., senior consultant in pediatric cardiology at Karolinska Institutet University Hospital in Stockholm, Sweden.
The current study isolated nicotine exposure by studying women who used only Swedish snus during pregnancy. Previous studies of women who smoke during pregnancy have consistently found adverse effects, including preterm birth, low birth weight and still birth. Studies have also found that children exposed to smoking while in utero have higher blood pressure. However, those studies could not separate the effect of nicotine from the effect of other smoking-related by-products. They also could not control for the second-hand smoke exposure that many children of tobacco smokers experience after birth.
In this study, the researchers measured blood pressure and heart rate in 21 children, five to six years of age, whose mothers used snus during pregnancy and 19 children of similar ages whose mothers used no tobacco products during pregnancy. They found that the systolic blood pressure of the children exposed to snus was 4.2 mmHg higher than the children with no nicotine exposure. (Systolic blood pressure is the top number in a blood pressure reading and is the force of the blood against the walls of the arteries when the heart is beating.)
“Although the increase in blood pressure is not clinically significant for an individual child, because blood pressure generally follows an upward trajectory throughout an individual’s life, it may increase more quickly to a point of clinical significance during adulthood, especially if paired with other risk factors such as obesity or inactivity,” said Nordenstam. “Tobacco products of any type should be avoided during pregnancy.”
Co-authors are: Mikael Norman M.D., Ph.D., and Ronny Wickström, M.D. Disclosures are in the manuscript.
The Swedish Medical Research Council, Swedish Council for Working Life and Social Research, the Samaritan Foundation, Odd Fellows Grand Lodge Sweden and the Childhood Foundation of the Swedish Order of Freemasons funded the study.
- Available multimedia is on right column of release link - https://newsroom.heart.org/news/children-are-more-likely-to-have-higher-blood-pressure-by-age-six-if-their-mother-used-snus-a-swedish-powdered-tobacco-product-during-pregnancy?preview=7331eaf3d9c28d717c6286f2097ff8dc
- Photograph of snus
- Years after pregnancy, cardiovascular risks track from mother to child
- Living tobacco-free
- After Oct. 16, view the manuscript online.
- Follow AHA/ASA news on Twitter @HeartNews
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA Volunteer Expert Perspective:
Darcy Spitz: 212-878-5940, email@example.com
AHA News Media in Dallas: 214-706-1173
For Public Inquiries: 1-800-AHA-USA1 (242-8721)